Publication | Closed Access

Specific immunotherapy reduces the antigen-dependent production of eosinophil chemotactic activity from mononuclear cells in patients with atopic asthma

AsthmaEosinophil Chemotactic ActivityAllergySpecific ImmunotherapyAllergy MedicineImmunologyImmunomodulationEosinophilic DisorderImmunotherapyMedicineAtopic Asthma